Identification and functional analysis of a novel type of MAP kinase superfamily.
Identification and functional analysis of a novel type of MAP kinase superfamily.
批准号:
11680696
负责人:
MIYATA Yoshihiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
MAP激酶超家族成员在多种信号转导途径中发挥重要作用。我们报道了MAP激酶超家族的一个新成员的分子克隆和表征。我们分离了小鼠和人类的cdna,编码一种新型蛋白激酶的完整开放阅读框,称为MOK。MOK包含蛋白丝氨酸/苏氨酸激酶共识基序,与MAP激酶超家族成员、MAK和MAK相关激酶(MRK)有一定的相似性。此外,与经典的MAP激酶一样,MOK在激活环域中具有一个Thr-Glu-Tyr (TEY)基序。MOK能够磷酸化几种已知的MAP激酶底物并进行自磷酸化。AEF的TEY基序突变可消除MOK的激酶活性,用磷酸酶抑制剂冈田酸处理细胞可增强MOK的激酶活性。发现佛波酯TPA可刺激MOK激酶活性。这些结果表明,MOK与MAP激酶超家族的已知亚家族成员有远亲关系,因此可以归类为新成员。接下来,我们寻找与MOK特异性相关的细胞蛋白。几个细胞蛋白,包括一个主要的90 kda分子伴侣HSP90,被发现与MOK相关。用格尔达霉素(一种hsp90特异性抑制剂)处理细胞后,MOK蛋白水平迅速降低,这是由于蛋白酶体依赖途径增强了MOK的降解。我们的数据表明,与HSP90的关联可能调节细胞内蛋白的稳定性和MOK的溶解度。密切相关的蛋白激酶MAK和MRK也被发现与HSP90相关,而传统的MAP激酶(ERK、p38和SAPK/JNK)与HSP90无关。此外,我们还发现在MOK-HSP90免疫复合物中特异性检测到Cdc37、HSC70、HSP70和HSP60等分子伴侣。
英文摘要
Members of the MAP kinase superfamily play important roles in a variety of signal transduction pathways. We report molecular cloning and characterization of a novel member of the MAP kinase superfamily. We isolated mouse and human cDNAs that encode complete open reading frames of a novel protein kinase, termed MOK.MOK contains the protein serine/threonine kinase consensus motifs and shows modest similarity to members of the MAP kinase superfamily and MAK and MAK-related kinase (MRK). In addition, MOK possesses a Thr-Glu-Tyr (TEY) motif in the activation loop domain, like classical MAP kinases. MOK is able to phosphorylate several known MAP kinase substrates and to undergo autophosphorylation. A mutation in the TEY motif to AEF abolished the kinase activity of MOK, and treatment of cells with a phosphatase inhibitor okadaic acid enhanced the kinase activity of MOK.Phorbol ester TPA was found to stimulate the kinase activity of MOK.These results indicate that MOK is distantly related to members of known subfamilies of the MAP kinase superfamily and therefore can be classified as a novel member.Next, we searched for cellular proteins that specifically associate with MOK.Several cellular proteins including a major 90-kDa molecular chaperone HSP90 were found associated with MOK.Treatment of cells with geldanamycin, an HSP90-specific inhibitor, rapidly decreased the protein level of MOK, and the decrease was attributed to enhanced degradation of MOK through proteasome-dependent pathways. Our data suggest that the association with HSP90 may regulate intracellular protein stability and solubility of MOK.Closely related protein kinases MAK and MRK were also found to associate with HSP90 while conventional MAP kinases (ERK, p38, and SAPK/JNK) were not associated with HSP90. In addition, we found that other molecular chaperones including Cdc37, HSC70, HSP70, and HSP60, were detected specifically in the MOK-HSP90 immunocomplexes.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Schnaider,T.: "Interaction of the human DnaJ homologue, HSJ1b with the 90 kDa heat shock protein, Hsp90."Life Sciences. 67. 1455-1465 (2000)
Schnaider,T.:“人类 DnaJ 同源物 HSJ1b 与 90 kDa 热休克蛋白 Hsp90 的相互作用。”生命科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyata,Y.: "Distantly related cousins of MAP kinase : Biochemical properties and possible physiological functions."Biochemical and Biophysical Research Communications. 266. 291-295 (1999)
Miyata,Y.:“MAP 激酶的远亲:生化特性和可能的生理功能。”生物化学和生物物理研究通讯。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyata,Y.: "Molecular cloning and characterization of a novel member of the MAP kinase superfamily."Genes to Cells. 4. 299-309 (1999)
Miyata,Y.:“MAP 激酶超家族新成员的分子克隆和表征。”基因到细胞。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyata,Y.: "p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90"Oncogene. 19. 1477-1484 (2000)
Miyata,Y.:“SV40 大 T 抗原和主要胞质热休克蛋白 HSP90 之间的 p53 独立关联”癌基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyata,Y.: "A strategy to make constitutively active MAP kinase by fusing with constitutively active MAP kinase kinase."Biochimica Biophysica Acta. 1451. 334-342 (1999)
Miyata,Y.:“通过与组成型活性 MAP 激酶激酶融合来制造组成型活性 MAP 激酶的策略。”《生物化学生物物理学学报》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Identification and functional analyses of cellular proteins that specifically interact with DYRK family protein kinases
-
批准号:20570129
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:MIYATA Yoshihiko
-
依托单位:
Analysis of cellular function of DYRK family protein kinases
-
批准号:17570110
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:MIYATA Yoshihiko
-
依托单位:
Analysis of physiological role of protein kinase MOK, a novel member of MAP kinase superfamily
-
批准号:13680781
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:MIYATA Yoshihiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于TLR4/P38MAPK/NF-ΚB通路的栀子苷和大黄素配伍抗脓毒症肠屏障炎性损伤研究
-
批准号:2026JJ81968
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邓怒骄
-
依托单位:
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
EGFR/MAPK/ERK信号通路介导肿瘤相关成纤维细胞分泌TNC导致复发/转移头颈部鳞状细胞癌免疫治疗抵抗的机制研究
-
批准号:JCZRLH202600215
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肠道菌群代谢物5-HTP负调控MAPK/ERK通路改善孤独症样行为的机制研究
-
批准号:JCZRQNB202600954
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于PD-1/PD-L1调控PI3K/AKT与MAPK/ERK通路探讨栀子苷-大黄素配伍改善脓毒症免疫抑制的作用
-
批准号:2026JJ81015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢伶俐
-
依托单位:
基于PTEN/MAPK/ERK轴的暖巢助孕方干预POI线粒体功能障碍研究
-
批准号:2026JJ81878
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈镇
-
依托单位:
USP13稳定MKK3调控p38/MAPK信号通路促进结直肠癌进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:常思雨
-
依托单位:
基于MAPK信号通路调控Th17/Treg免疫平衡探讨肉芽肿性乳腺炎“因郁致痈”的科学内涵及柴胡清肝汤作用机制研究
-
批准号:2026JJ70069
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邓显光
-
依托单位:
基于谱效关系和MAPK/ERK信号的吴茱萸酒制前后配伍当归治疗原发性痛经物质基础和作用机制研究
-
批准号:2026JJ82685
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘叶倩
-
依托单位:
免疫微环境重塑驱动MAPK–VEGF-C/VEGFR-3信号轴调控巨噬细胞促淋巴管再生的机制研究
-
批准号:JCZRQNB202600447
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: